Testosterone Replacement Therapy and the Risk of Hypoglycemia.

Analía Verónica YamaguchiPablo René CostanzoVerónica Andrea PeuchotPablo Knoblovits

Published in: Case reports in endocrinology (2019)

We report the case of a 45-year-old man with a history of Klinefelter syndrome undergoing testosterone replacement therapy, and with type 2 diabetes treated with metformin with poor metabolic control. When vildagliptin was added to his treatment, he presented hypoglycemia after the testosterone injection. We highlight this not widely reported drug interaction between hypoglycemic agents and testosterone.

Keyphrases

replacement therapy
smoking cessation
type diabetes
glycemic control
emergency department
insulin resistance
ultrasound guided
newly diagnosed
drug induced